Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Lineage Cell Therapeutics, Inc. LCTX | BlackRock Inc. BLK | 2,234,545 1.000% | -9,218,760 (-80.49%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Magnera Corp. MAGN | BlackRock Inc. BLK | 2,519,401 7.100% | 2,519,401 (New Position) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Marriott Vacations Worldwide Corporation VAC | BlackRock Inc. BLK | 3,837,136 11.100% | 694,966 (+22.12%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Mersana Therapeutics, Inc. MRSN | BlackRock Inc. BLK | 150,475 3.000% | -182,480 (-54.81%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Capitol Federal Financial, Inc. CFFN | BlackRock Inc. BLK | 17,580,461 13.200% | -2,280,704 (-11.48%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Cars.com Inc. CARS | BlackRock Inc. BLK | 8,685,400 13.800% | -1,313,330 (-13.13%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Clover Health Investments, Corp. CLOV | BlackRock Inc. BLK | 29,813,646 7.200% | 22,041,542 (+283.60%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Day One Biopharmaceuticals, Inc. DAWN | BlackRock Inc. BLK | 5,849,917 5.800% | 1,037,610 (+21.56%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Destination XL Group, Inc. DXLG | BlackRock Inc. BLK | 866,987 1.600% | -2,996,626 (-77.56%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Douglas Elliman Inc. DOUG | BlackRock Inc. BLK | 4,725,524 5.300% | 3,563,614 (+306.70%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | D-Wave Quantum Inc. QBTS | BlackRock Inc. BLK | 22,170,378 7.100% | 22,170,378 (New Position) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | EQT Corporation EQT | BlackRock Inc. BLK | 40,723,549 6.800% | 8,270,642 (+25.49%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Edgewise Therapeutics, Inc. EWTX | BlackRock Inc. BLK | 5,824,866 5.500% | -568,701 (-8.89%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | eHealth, Inc. EHTH | BlackRock Inc. BLK | 1,885,419 6.200% | 762,976 (+67.97%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Eledon Pharmaceuticals, Inc. ELDN | BlackRock Inc. BLK | 3,252,910 5.400% | 3,252,910 (New Position) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Elevation Oncology, Inc. ELEV | BlackRock Inc. BLK | 369,048 0.600% | -2,794,132 (-88.33%) | Filing History |
| 2025-07-17 7:54 pm Purchase | 2025-06-30 | 13G | Emergent BioSolutions Inc. EBS | BlackRock Inc. BLK | 3,977,535 7.300% | 2,008,751 (+102.03%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | Energizer Holdings, Inc. ENR | BlackRock Inc. BLK | 9,444,025 13.100% | -1,282,768 (-11.96%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | EnPro Industries, Inc. NPO | BlackRock Inc. BLK | 3,046,596 14.500% | -281,118 (-8.45%) | Filing History |
| 2025-07-17 7:54 pm Sale | 2025-06-30 | 13G | ESSA Bancorp, Inc. ESSA | BlackRock Inc. BLK | 488,126 4.800% | -23,304 (-4.56%) | Filing History |